NOVARTIS
Rhapsido
Resolved
280days ago
Approval decision · Sep 30, 2025
What's at stake
A final FDA approval decision on Rhapsido for its lead indication is expected Sep 30, 2025.
Primary source
· openFDA
verified 18h ago
“FDA approved Rhapsido (NDA218436) — sponsor NOVARTIS; new molecular entity / original approval; FDA action date 2025-09-30.”